Neogen Valuation

NEOG Stock  USD 4.74  0.12  2.47%   
At this time, the firm appears to be undervalued. Neogen secures a last-minute Real Value of $5.68 per share. The latest price of the firm is $4.74. Our model forecasts the value of Neogen from analyzing the firm fundamentals such as Current Valuation of 1.9 B, return on equity of -0.17, and Profit Margin of (0.54) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Neogen's valuation include:
Price Book
1.2089
Enterprise Value
1.9 B
Enterprise Value Ebitda
25.0715
Price Sales
1.1642
Forward PE
16
Undervalued
Today
4.74
Please note that Neogen's price fluctuation is moderately volatile at this time. Calculation of the real value of Neogen is based on 3 months time horizon. Increasing Neogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Neogen stock is determined by what a typical buyer is willing to pay for full or partial control of Neogen. Since Neogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neogen Stock. However, Neogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.74 Real  5.68 Target  9.0 Hype  4.79 Naive  4.28
The real value of Neogen Stock, also known as its intrinsic value, is the underlying worth of Neogen Company, which is reflected in its stock price. It is based on Neogen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
5.68
Real Value
10.07
Upside
Estimating the potential upside or downside of Neogen helps investors to forecast how Neogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neogen more accurately as focusing exclusively on Neogen's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.08-0.030.10
Details
Hype
Prediction
LowEstimatedHigh
0.404.799.18
Details
Naive
Forecast
LowNext ValueHigh
0.094.288.67
Details
3 Analysts
Consensus
LowTarget PriceHigh
8.199.009.99
Details
When choosing an evaluation method for Neogen, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.

Neogen Cash

206.01 Million

Neogen Valuation Trend

Comparing Neogen's enterprise value against its market capitalization is a good way to estimate the value of Neogen uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.

Neogen Revenue by Product

Neogen Total Value Analysis

Neogen is now estimated to have valuation of 1.9 B with market capitalization of 1.05 B, debt of 906.24 M, and cash on hands of 347.71 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Neogen fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.9 B
1.05 B
906.24 M
347.71 M

Neogen Investor Information

About 100.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neogen has Price/Earnings To Growth (PEG) ratio of 0.66. The entity recorded a loss per share of 2.23. The firm had not issued any dividends in recent years. Neogen had 2:1 split on the 7th of June 2021. Based on the analysis of Neogen's profitability, liquidity, and operating efficiency, Neogen may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.

Neogen Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Neogen implies not a very effective usage of assets in July.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Neogen Ownership Allocation

The majority of Neogen outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Neogen to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Neogen. Please pay attention to any change in the institutional holdings of Neogen as this could imply that something significant has changed or is about to change at the company.

Neogen Profitability Analysis

The company reported the previous year's revenue of 924.22 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 442 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Neogen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Neogen and how it compares across the competition.

About Neogen Valuation

The stock valuation mechanism determines Neogen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Neogen. We calculate exposure to Neogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neogen's related companies.
Last ReportedProjected for Next Year
Gross Profit533.5 M560.2 M
Pretax Profit Margin(0.01)(0.01)
Operating Profit Margin 0.06  0.07 
Net Loss(0.01)(0.01)
Gross Profit Margin 0.58  0.57 

Neogen Growth Indicators

Investing in growth stocks can be very risky. If the company such as Neogen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding216.5 M
Quarterly Earnings Growth Y O Y-0.856
Forward Price Earnings16

Neogen Current Valuation Indicators

Valuation refers to the process of determining the present value of Neogen and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Neogen we look at many different elements of the entity such as Neogen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Neogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Neogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Neogen's worth.

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Valuation
Check real value of public entities based on technical and fundamental data